STEVENSON, Md. -- (Business Wire)
The securities litigation law firm of Brower Piven, A Professional
Corporation, announces that a class action lawsuit has been commenced in
the United States District Court for the Eastern District of
Pennsylvania on behalf of purchasers of Teva Pharmaceutical Industries
Limited (NYSE: TEVA) (“Teva” or the “Company”) American Depository
Shares (“ADSs”) and/or shares on the Tel Aviv Stock Exchange between
November 15, 2016 and August 2, 2017, inclusive (the “Class Period”).
Investors who wish to become proactively involved in the litigation have
until October 23, 2017 to seek appointment as lead plaintiff.
If you wish to choose counsel to represent you and the class, you must
apply to be appointed lead plaintiff and be selected by the Court. The
lead plaintiff will direct the litigation and participate in important
decisions including whether to accept a settlement for the class in the
action. The lead plaintiff will be selected from among applicants
claiming the largest loss from investment in Teva securities during the
Class Period. Members of the class will be represented by the lead
plaintiff and counsel chosen by the lead plaintiff. No class has yet
been certified in the above action.
The complaint accuses the defendants of violations of the Securities
Exchange Act of 1934 by virtue of the defendants’ failure to disclose
during the Class Period that the acquisition and integration of Actavis
Generics (“Actavis”) was having a negative impact on the Company’s
financial results.
According to the complaint, following an August 3, 2017 announcement of
lower than anticipated second quarter results due to the performance of
the U.S. generics business and a recorded goodwill impairment charge
related to the Actavis acquisition, the value of Teva depositary shares
declined significantly.
If you have suffered a loss in excess of $100,000 from investment in
Teva securities purchased on or after November 15, 2016 and held through
the revelation of negative information during and/or at the end of the
Class Period and would like to learn more about this lawsuit and your
ability to participate as a lead plaintiff, without cost or obligation
to you, please visit our website at http://www.browerpiven.com/currentsecuritiescases.html.
You may also request more information by contacting Brower Piven either
by email at hoffman@browerpiven.com
or by telephone at (410) 415-6616.
Attorneys at Brower Piven have extensive experience in litigating
securities and other class action cases and have been advocating for the
rights of shareholders since the 1980s. If you choose to retain counsel,
you may retain Brower Piven without financial obligation or cost to you,
or you may retain other counsel of your choice. You need take no action
at this time to be a member of the class.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170919006287/en/
Contacts:
Brower Piven, A Professional Corporation
Charles J. Piven,
410-415-6616
1925 Old Valley Road
Stevenson, Maryland 21153
hoffman@browerpiven.com
Source: Brower Piven, A Professional Corporation
© 2024 Canjex Publishing Ltd. All rights reserved.